Diligence memo · auto-generated · as of July 2, 2026
MicroNeb, Inc.
MicroNeb, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
MicroNeb, Inc. operates in Pharmaceuticals, based in ST. PETERSBURG.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
MicroNeb, Inc. has raised $150K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $150K on 2023-06-07.
Most recent recorded round closed around 2023-06-07.
Valuation (modeled)modeled
Provath models MicroNeb, Inc. at approximately $1.3M (range $84K–$5.9M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.50× the median modeled value of Pre-Seed Pharmaceuticals companies in 2022–2024 (38 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 3.1 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 3% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 3% of those peers.
Closest niche peers: Eleison Pharmaceuticals Inc, Telomir Pharmaceuticals, Inc., Drusolv Therapeutics, Inc., TF Tech Ventures, Inc., Thyron Pharmaceuticals, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.